Effects of SARS-CoV-2 gestational exposure and risk factors on neurodevelopment until 12 months: A prospective cohort study in Brazil

Abstract

BackgroundThe effects of SARS-CoV-2 gestational exposure on child development remain inconclusive. AimsTo analyze the effects of SARS-CoV-2 gestational exposure on neurodevelopment until 12 months. Study designProspective cohort study conducted in five municipalities in Southeast Brazil from August 2021 to September 2022. SubjectsInfants were recruited from a serological survey performed during neonatal screening and followed up to 12 months old. We included 224 infants exposed to SARS-CoV-2 during pregnancy and 225 non-exposed, according to the serology results of the newborn as well as their mothers and the maternal antenatal RT-PCR results. Outcome measuresDevelopmental assessments were performed at 6 and 12 months using the Survey of Wellbeing of Young Children-Brazilian Version (SWYC-BR). Children with suspected developmental delay (SDD) at 6 and 12 months were considered at high risk for developmental delay (HRDD). Additionally, risk factors associated with SDD were examined. ResultsThere were 111 children identified with SDD and 52 with HRDD. SARS-CoV-2 gestational exposure was not associated with SDD. Exposure in the first gestational trimester increased SDD risk by 2.15 times compared to the third. Cesarean delivery predicted SDD (OR 1.56; 95%CI 1.01–2.42) and HRDD (OR 1.91; 95%CI 1.04–3.48). Additionally, suspected maternal depression predicted SDD (OR 1.76; 95%CI 1.01–3.10). ConclusionSARS-CoV-2 gestational exposure did not increase the developmental delay risk. However, our findings suggest that the earlier the gestational exposure, the greater the developmental delay risk at 12 months. Cesarean delivery and suspected maternal depression increased the developmental delay risk, independent of virus exposure.